Abstract
It has been half a century since K. Takeuchi and K. Shimizu first reported a new entity in vascular disease in 1957, moyamoya disease (MMD) [1]. This disease is a relatively rare vascular disease and has a high prevalence in children and Asian ethnics; thus, it has not been of great interest to physicians and researchers in non-Asian countries. The Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare in Japan launched a project in 1977 to investigate the disease, and continues to study its pathogenesis, epidemiology, and treatment. Most of the reported literature about MMD is from Japan. The annual report of the Committee has accumulated many clinical as well as research data, and studies are ongoing. The incidence of reports on MMD is increasing in Western countries. It is important to understand the current status of MMD management with its unsolved problems. No standardized surgical method of choice has yet been established. One reason for this is the absence of standardized evaluation measures and protocols. Here, current evaluation measures for pre- and post-operative outcomes are reviewed, and novel therapeutic research trials are presented as potential future perspectives on this disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Takeuchi K, Shimizu K (1957) Hypogenesis of bilateral internal carotid artery. No To Shinkei 9:37–43
Matsushima T, Fujiwara S, Nagata S et al (1989) Surgical treatment for pediatric patients with moyamoya disease by indirect revascularization procedures (EDAS, EMS, EMAS). Acta Neurochir 98:135–140
Matsushima T, Inoue T, Suzuki SO (1992) Surgical treatment of moyamoya disease in pediatric patients-comparison the results of indirect and direct revascularization procedures. Neurosurgery 31:401–405
Kim SK, Wang KC, Kim IO et al (2002) Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery 50:88–96
Czabanka M, Vajkoczy P, Schmiedek P (2009) Age-dependent revascularization patterns in the treatment of moyamoya disease in European patient population. Neurosurg Focus 26(4):E9
Matsushima Y, Aoyagi M, Niimi Y et al (1990) Symptoms and their pattern of progression in childhood moyamoya disease. Brain Dev 12(6):784–789
Horn P, Vajkoczy P, Schmiedek P et al (2004) Evaluation of extracranial-intracranial arterial bypass function with magnetic resonance angiography. Neuroradiology 46:723–729
Houkin K, Nakayama N, Kuroda S et al (2005) Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis 20:347–354
Perren F, Meairs S, Schmiedek P et al (2005) Power Doppler evaluation of revascularization in childhood moyamoya. Neurology 64:558–560
Sato H, Sato N, Tamaki N et al (1990) Chronic low-perfusion state in children with moyamoya disease following revascularization. Childs Nerv Syst 6(3):166–171
Ikezaki K, Matsushima T, Kuwabara Y et al (1994) Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 81:843–850
Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future prospective. Lancet Neurol 7:1056–1066
Guzman R, Lee M, Achrol A et al (2009) Clinical outcome after 450 revascularization procedures for moymoy disease. J Neurosurg. doi: 10.3171/2009.4.JNS081649
Veeravagu A, Guzman R, Path CG et al (2008) Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus 24(2):1–9
Yamashita T, Deguchi K, Nagotani S et al (2009) Gene and stem cell therapy in ischemic stroke. Cell Transplant Apr 29 Pii:CT-2061 [Epub ahead of print]
Toyama K, Honmou O, Harada K et al (2009) Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 216(1):47–55
Zhu W, Fan Y, Hao Q et al (2009) Postischemic IGF-1 gene transfer promotes neurovascular regeneration after experimental stroke. J Cereb Blood Flow Metab 29(9):1528–1537
Chen C, Hu Q, Yan J et al (2009) Early inhibition of HIF-1alpha with small interfering RNA reduce ischemic-reperfused brain injury in rats. Neurobiol Dis 33(3):509–517
Lee HJ, Kim MK, Kim HJ et al (2009) Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model. PLoS One 4(5):e5586
Perren F, Horn P, Vajkoczy P et al (2005) Power Doppler imaging in detection of surgically induced indirect neoangiogenesis in adult moyamoya disease. J Neurosurg 103:869–872
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer
About this chapter
Cite this chapter
Cho, BK. (2010). Future Perspectives in Moyamoya Disease. In: Cho, BK., Tominaga, T. (eds) Moyamoya Disease Update. Springer, Tokyo. https://doi.org/10.1007/978-4-431-99703-0_52
Download citation
DOI: https://doi.org/10.1007/978-4-431-99703-0_52
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-99702-3
Online ISBN: 978-4-431-99703-0
eBook Packages: MedicineMedicine (R0)